关于多发性骨髓瘤的新鲜事物来自主要的2024年血液学会议
Sonia Morè1,2, Laura Corvatta3, Valentina Maria Manieri1,2
1Clinica di Ematologia, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy.
Mediterranean journal of hematology and infectious diseases
|March 14, 2025
概括
新的多发性骨髓瘤 (MM) 疗法显示出前景,前期四胞胎改善了结果. 双特异性抗体和CAR-T细胞为高级MM提供了新的前沿,特别是在复发或高风险患者中.
科学领域:
- 血液瘤学 血液瘤学
- 免疫治疗是一种免疫疗法.
- 临床试验数据
背景情况:
- 多发性骨髓瘤 (MM) 由于患者异质性而带来了重大治疗挑战.
- 尽管最近的治疗进展,实现最佳的结果,特别是高风险或晚期疾病,仍然很困难.
研究的目的:
- 审查在2024年主要国际会议上提出的多发性骨髓瘤治疗的重大进展.
- 突出新的治疗策略及其对患者结果的影响,特别是在具有挑战性的MM病例中.
主要方法:
- 审查了2024年在主要国际血液学会议上提交的数据.
- 对前期四重组合结果的分析,包括抗CD38单克隆抗体.
- 评估新兴疗法,如对高级MM的双特异抗体和CAR-T细胞.
主要成果:
- 前期四重组疗法在适合移植和不适合移植的患者中显示出更高的响应深度和长期疗效.
- 最小残留疾病 (MRD) 的评估对于指导治疗持续时间和避免过度治疗至关重要.
- 高风险的细胞遗传学和循环瘤细胞仍然是四重治疗的挑战,需要替代策略.
- 双特异性抗体和CAR-T细胞在早期复发和高风险患者中显示出高疗效,毒性降低.
- 新型免疫疗法在预先设置中显示出有希望的结果.
结论:
- 四重组合代表了前期多发性骨髓瘤治疗的重大进步.
- 双特异性抗体和CAR-T细胞正在成为高级和复发性/耐药性MM的强大工具.
- 个性化治疗选择是必不可少的,考虑到患者的健康状况和特定疾病特征.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.7K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.4K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:22Bone Marrow Sampling and Transplants
269
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
269
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K